Skip to content

On this page

Verluma

nofetumomab

351(a) Standalone BLA

Overview

Source: Purple Book

Proprietary name

Verluma

Proper name

nofetumomab

Licence type

351(a)

BLA number

103769

Applicant

Boehringer Ingelheim Pharma GmbH & Co. KG

Center

CDER

Presentations

1

First licensure

—

Presentations

Source: Purple Book

Every strength and presentation recorded in the Purple Book for this product.
Strength	Dosage form	Route	Presentation	Status	Licensed
10MG/ML	Injection	Intravenous	—	Disc	October 13, 1998

Sources for this page

Purple Book	FDA	Licence type, presentations, reference product, exclusivity